糖尿病肾病中血管紧张素转换酶抑制剂与血管紧张素受体阻滞剂的比较：有优胜者吗？ - Suppr

Suppr

超能文献

ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?

作者信息

Lewis Edmund J, Lewis Julia B

机构信息

Rush University Medical Center, Chicago, Illinois, USA.

出版信息

J Am Soc Nephrol. 2004 May;15(5):1358-60.

PMID:15100380

Abstract

摘要

相似文献

ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?

J Am Soc Nephrol. 2004 May;15(5):1358-60.

[Threatened diabetic nephropathy. Early administration of ACE inhibitors and AT1 blockers].

MMW Fortschr Med. 2002 Apr 11;144(15):14.

Angiotensin II receptor blockade in diabetic nephropathy.

Dan Med Bull. 2004 Aug;51(3):274-94.

Toward better renoprotection: lessons from angiotensin receptor blockers.

Hemodial Int. 2007 Apr;11(2):164-8. doi: 10.1111/j.1542-4758.2007.00164.x.

[Mechanism of action of ACE-inhibitors and angiotensin receptor antagonists in diabetic nephropathy. Recent insights].

Recenti Prog Med. 2003 Mar;94(3):131-5.

Diabetic nephropathy.

N Engl J Med. 2002 Sep 19;347(12):947-8; author reply 947-8. doi: 10.1056/NEJM200209193471218.

The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.

Arch Intern Med. 1992 Oct;152(10):2137-9.

Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].

Isr Med Assoc J. 2004 May;6(5):296-8.

[Kidney failure, proteinuria, and diabetic nephropathy].

Rev Med Brux. 2003 Sep;24(4):A257-62.

Dual blockade of the renin-angiotensin system in diabetic nephropathy.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1278-82. doi: 10.1345/aph.1D598. Epub 2004 Jun 8.

引用本文的文献

Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy.

Front Physiol. 2021 Jan 22;11:612722. doi: 10.3389/fphys.2020.612722. eCollection 2020.

Congenital urinary tract obstruction: the long view.

Adv Chronic Kidney Dis. 2015 Jul;22(4):312-9. doi: 10.1053/j.ackd.2015.01.012.

Classical Renin-Angiotensin system in kidney physiology.

Compr Physiol. 2014 Jul;4(3):1201-28. doi: 10.1002/cphy.c130040.

Management of diabetic hypertensives.

Indian J Endocrinol Metab. 2011 Oct;15 Suppl 4(Suppl4):S374-9. doi: 10.4103/2230-8210.86982.

[Improved effectiveness in the management of cardiovascular risk among type 2 diabetic patients in primary health care].

Aten Primaria. 2009 May;41(5):240-5. doi: 10.1016/j.aprim.2008.09.006. Epub 2009 Apr 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?

作者信息

Lewis Edmund J, Lewis Julia B

机构信息

Rush University Medical Center, Chicago, Illinois, USA.

出版信息

J Am Soc Nephrol. 2004 May;15(5):1358-60.

PMID:15100380

Abstract

摘要

相似文献

ACE inhibitors versus angiotensin receptor blockers in diabetic nephropathy: is there a winner?

J Am Soc Nephrol. 2004 May;15(5):1358-60.

[Threatened diabetic nephropathy. Early administration of ACE inhibitors and AT1 blockers].

MMW Fortschr Med. 2002 Apr 11;144(15):14.

Angiotensin II receptor blockade in diabetic nephropathy.

Dan Med Bull. 2004 Aug;51(3):274-94.

Toward better renoprotection: lessons from angiotensin receptor blockers.

Hemodial Int. 2007 Apr;11(2):164-8. doi: 10.1111/j.1542-4758.2007.00164.x.

[Mechanism of action of ACE-inhibitors and angiotensin receptor antagonists in diabetic nephropathy. Recent insights].

Recenti Prog Med. 2003 Mar;94(3):131-5.

Diabetic nephropathy.

N Engl J Med. 2002 Sep 19;347(12):947-8; author reply 947-8. doi: 10.1056/NEJM200209193471218.

The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.

Arch Intern Med. 1992 Oct;152(10):2137-9.

Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].

Isr Med Assoc J. 2004 May;6(5):296-8.

[Kidney failure, proteinuria, and diabetic nephropathy].

Rev Med Brux. 2003 Sep;24(4):A257-62.

Dual blockade of the renin-angiotensin system in diabetic nephropathy.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1278-82. doi: 10.1345/aph.1D598. Epub 2004 Jun 8.

引用本文的文献

Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy.

Front Physiol. 2021 Jan 22;11:612722. doi: 10.3389/fphys.2020.612722. eCollection 2020.

Congenital urinary tract obstruction: the long view.

Adv Chronic Kidney Dis. 2015 Jul;22(4):312-9. doi: 10.1053/j.ackd.2015.01.012.

Classical Renin-Angiotensin system in kidney physiology.

Compr Physiol. 2014 Jul;4(3):1201-28. doi: 10.1002/cphy.c130040.

Management of diabetic hypertensives.

Indian J Endocrinol Metab. 2011 Oct;15 Suppl 4(Suppl4):S374-9. doi: 10.4103/2230-8210.86982.

[Improved effectiveness in the management of cardiovascular risk among type 2 diabetic patients in primary health care].

Aten Primaria. 2009 May;41(5):240-5. doi: 10.1016/j.aprim.2008.09.006. Epub 2009 Apr 8.